2020 (11th) International Conference on Cell Therapy
Focus on stem cell & regenerative medicine, CAR-T , cancer immunotherapy, gene therapy, and more.
The Wuxi International Bioforum 2019 and The 9th Cell Death & Disease Symposium - New Drug Discovery
Internationally renowned leading scientists and pioneers will present cutting-edge advances in cancer immunotherapy, targeted therapy with small molecules,and/or monoclonal antibodies, and novel cell therapeutic strategies. . New challenges, topical directions and novel approacheswill be discussed.
2019 (10th) International Conference on Cell Therapy
Although cell therapy has been on its fast lane, all colleagues in this field still have a long way to go due to the difficulty in treatment of solid tumors and the high cost of T cells. It is believed that many people are looking forward to the approval of Chinese cell therapy products.
2019 (5th) International Conference on Gut Microecology and Health
At present, gut microbiome is a hot topic, which draws much attention. Due to its curative effects on multiple diseases, gut microbiome is closely related to human health. Under the development of microbe imaging, metabolomics and single-cell sequencing technologies, new progress has been made in this field.
2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
Chimeric antigen receptors are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
2018 ( 10th ) International Conference on Stem Cells
After nearly 20 years' development, there have been almost 100 companies focusing on technology R&D on stem cells, establishment of stem cell banks and application of stem cells. This conference will facilitate communication and cooperation among researchers at home and abroad.
2018 International Forum on Innovative Drug R&D
With a population of 1.3 billion people and a rapidly expanding economy, China has recently risen to become the third largest pharmaceutical market globally. Several multinational pharmaceutical companies have now located R&D centres in China, and Chinese pharmaceutical companies are increasingly focusing on innovative drug R&D.
2018 International Forum on Rare Diseases and Orphan Drugs
In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs are ones so created or sold.
2018 International Symposium on Neonatal Hereditary Diseases and Translational Medicine
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.
2018 International Forum on Biotechnological Drugs
Biotechnological drugs are a wide group of therapeutic agents obtained by means of genetic engineering methodologies. This forum will provide you with the latest technologies, the whole industry and the market of novel antibodies, antibody drugs, new vaccine development, new vaccine industry, protein modification in China.